BRIGHT MINDS BIOSCIENCES INC. (DRUG) earnings per share
BRIGHT MINDS BIOSCIENCES INC. reports in CAD; the
per-share figures below are in CAD as filed with SEC
EDGAR, not US dollars.
Annual history
Fiscal years 2021 – 2024
CAD / SHARE 5 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2024 | 2024-09-30 | -C$0.65 | 2024-12-31 |
| FY 2023 | 2023-09-30 | -C$1.98 | 2023-12-29 |
| FY 2022 | 2022-09-30 | -C$6.06 | 2022-12-29 |
| FY 2021 | 2021-09-30 | -C$4.82 | 2022-01-18 |
| FY 2021 | 2020-09-30 | -C$0.13 | 2022-01-18 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (1 split since 2023).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
DRUG CIK 0001827401 Source: EDGAR filings · all facts